Jortan Pharmaceuticals

Aspartic protease inhibitors as therapy for diabetes

placeOklahoma City, Oklahoma, United States calendar_todayFounded 2013 language jortanpharma.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 5 times.

YearFilings
20171

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon